清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Biological Activity Assays for Antibody Therapeutics

生物测定 效力 生物活性 计算生物学 药理学 生化工程 生物 体外 生物化学 工程类 遗传学
作者
Xu‐Rong Jiang,Anthony R. Mire‐Sluis
出处
期刊:AAPS advances in the pharmaceutical sciences series [Springer Nature]
卷期号:: 393-430 被引量:1
标识
DOI:10.1007/978-3-319-99680-6_16
摘要

The measurement of biological activity is required for therapeutic antibodies at release of a new manufacturing batch and throughout the product life cycle. However, the applicable regulatory guidelines provide relatively little advice with respect to the number and types of bioassays to be employed. For example, 21CFR610.10 states that potency tests “shall consist of either in vitro or in vivo tests, or both, which have been specifically designed for each product so as to indicate its potency in a manner adequate to satisfy the interpretation of potency” where potency is “the specific ability of capacity of the product, as indicated by appropriate laboratory tests or by adequately controlled clinical data obtained through the administration of the product in the manner intended, to effect a given result.” ICH Q6B lists animal-based biological tests, cell culture-based biological tests, biochemical tests and ligand and receptor binding tests as examples of biological tests. However, neither guideline provides any assistance on how to select the most appropriate bioassay format(s) for a given product. Since biological activity is determined based on individual product characteristics and mechanism of action, there is considerable decision-making involved when selecting, developing, switching, and maintaining appropriate bioassays. This chapter discusses the types of biological assays, the current practices and regulatory expectations regarding the potency test format. A key question for antibody therapeutics that acts as agonists or antagonists of a ligand-receptor interaction, is the question of cell-based versus binding assays. Development and validation considerations for biological assays will also be discussed. This chapter will particularly focus on special considerations for biosimilar antibody therapeutics and provide a strategy for the biological testing methods, plan, and statistical assessment for the assessment of functional biosimilarity. Key differences in the application of a battery of in vitro biological activity assays between a biosimilar and a novel biologic, and case studies will be discussed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
scenery0510发布了新的文献求助10
4秒前
周立杰完成签到,获得积分10
11秒前
leapper完成签到 ,获得积分10
15秒前
JJYYY发布了新的文献求助10
16秒前
Maestro_S的应助被科研通管家采纳,获得10
17秒前
Maestro_S的应助被科研通管家采纳,获得10
17秒前
17秒前
白菜萝卜完成签到 ,获得积分10
29秒前
JJYYY完成签到,获得积分10
29秒前
尊敬的千凡完成签到,获得积分10
34秒前
KINGAZX完成签到 ,获得积分10
37秒前
huanhuan完成签到 ,获得积分10
43秒前
黑猫老师完成签到 ,获得积分10
47秒前
49秒前
lyb1853完成签到 ,获得积分10
58秒前
失眠的热狗完成签到,获得积分10
1分钟前
1分钟前
KalEl发布了新的文献求助10
1分钟前
Nene完成签到 ,获得积分10
1分钟前
永乐完成签到 ,获得积分10
1分钟前
Gone完成签到,获得积分10
1分钟前
激动的似狮完成签到,获得积分0
1分钟前
1分钟前
1分钟前
机灵善斓完成签到,获得积分10
1分钟前
吃葡萄不吐葡萄皮的应助被HNO3采纳,获得10
1分钟前
1分钟前
syvshc完成签到,获得积分0
2分钟前
感动初蓝完成签到 ,获得积分10
2分钟前
害羞不凡完成签到,获得积分10
2分钟前
2分钟前
2分钟前
KalEl发布了新的文献求助10
2分钟前
molihuakai的应助被TingtingGZ采纳,获得10
2分钟前
呆萌尔风完成签到,获得积分10
2分钟前
2分钟前
怡然涫完成签到,获得积分10
2分钟前
佳伦完成签到 ,获得积分10
2分钟前
智者雨人完成签到 ,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173213
求助须知:如何正确求助?哪些是违规求助? 9565567
关于积分的说明 21780511
捐赠科研通 7767373
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555730
邀请新用户注册赠送积分活动 2476697